{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:47:21Z","timestamp":1784274441215,"version":"3.55.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>To determine maternal and neonatal risk factors for, and incidence of, neonatal early-onset group B streptococcus (EOGBS) and late-onset (LOGBS) infection in South Australia (SA) and the Northern Territory (NT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A case\u2013control study with 2:1 matched controls to cases. The study included tertiary hospitals in South Australia and the Northern Territory, Australia. Retrospective data were collected from a 16-year epoch (2000\u20132015).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of a total of 188 clinically suspected or confirmed cases, 139 were confirmed, of which 56.1% (n = 78) were EOGBS and 43.9% (n = 61) were LOGBS. The incidence of clinically suspected and confirmed cases of EOGBS was 0.26\/1000 live births in SA and 0.73\/1000 live births in the NT, and the incidence of confirmed cases was 0.19\/1000 for SA and 0.36\/1000 for the NT. The incidence of clinically suspected or confirmed LOGBS was 0.18\/1000 live births in SA and 0.16\/1000 for the NT. The majority of infants with GBS presented with sepsis, pneumonia, or meningitis. Developmental delay was the most commonly recorded long-term complication at 1 year old. Risk factors for EOGBS included maternal GBS carriage, previous fetal death, identifying as Aboriginal and\/or Torres Strait Islander, and maternal fever in labor\/chorioamnionitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>GBS remains a leading cause of neonatal morbidity and mortality. Adding previous fetal death to GBS screening guidelines would improve GBS prevention. The introduction of maternal GBS vaccination programs should be guided by country-specific disease epidemiology.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003881","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T15:00:07Z","timestamp":1679065207000},"page":"429-435","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Neonatal Group B Streptococcal Infection in Australia: A Case\u2013control Study"],"prefix":"10.1097","volume":"42","author":[{"given":"Marianne","family":"Yanni","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Women\u2019s and Children\u2019s Health Network, Adelaide, South Australia, Australia"},{"name":"Robinson Research Institute and Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stark","sequence":"additional","affiliation":[{"name":"Robinson Research Institute and Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia"},{"name":"Department of Neonatology, Women\u2019s and Children\u2019s Health Network, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Francis","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Royal Darwin Hospital, Tiwi, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua R.","family":"Francis","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Royal Darwin Hospital, Tiwi, Northern Territory, Australia"},{"name":"Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Casuarina, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6490-7707","authenticated-orcid":false,"given":"Mark","family":"McMillan","sequence":"additional","affiliation":[{"name":"Robinson Research Institute and Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia"},{"name":"Vaccinology and Immunology Research Trials Unit, Women\u2019s and Children\u2019s Health Network, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Baird","sequence":"additional","affiliation":[{"name":"Territory Pathology, Royal Darwin Hospital, Tiwi, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Heath","sequence":"additional","affiliation":[{"name":"Paediatric Infectious Diseases Research Group & Vaccine Institute St George\u2019s, University of London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Gordon","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Women\u2019s and Children\u2019s Health Network, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Riccardione","sequence":"additional","affiliation":[{"name":"Territory Pathology, Royal Darwin Hospital, Tiwi, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Wilson","sequence":"additional","affiliation":[{"name":"Territory Pathology, Royal Darwin Hospital, Tiwi, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Royal Darwin Hospital, Tiwi, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrina","family":"Chooi","sequence":"additional","affiliation":[{"name":"Vaccinology and Immunology Research Trials Unit, Women\u2019s and Children\u2019s Health Network, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia-Paris","family":"Quinn","sequence":"additional","affiliation":[{"name":"Vaccinology and Immunology Research Trials Unit, Women\u2019s and Children\u2019s Health Network, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen S.","family":"Marshall","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Women\u2019s and Children\u2019s Health Network, Adelaide, South Australia, Australia"},{"name":"Robinson Research Institute and Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia"},{"name":"Vaccinology and Immunology Research Trials Unit, Women\u2019s and Children\u2019s Health Network, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.wombi.2012.10.004","article-title":"Assisting women to make informed choices about screening for group B streptococcus in pregnancy: a critical review of the evidence.","volume":"26","author":"Sheehy","year":"2013","journal-title":"Women Birth"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1440-1754.2011.02203.x","article-title":"Prevention of neonatal group B streptococcus disease in the 21st century.","volume":"48","author":"Clifford","year":"2012","journal-title":"J Paediatr Child Health"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1001\/jama.299.17.2056","article-title":"Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005.","volume":"299","author":"Phares","year":"2008","journal-title":"JAMA"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1542\/peds.2010-2217","article-title":"Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues.","volume":"127","author":"Stoll","year":"2011","journal-title":"Pediatrics"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"D7","DOI":"10.1016\/j.vaccine.2013.01.009","article-title":"An overview of global GBS epidemiology.","volume":"31","author":"Le Doare","year":"2013","journal-title":"Vaccine"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1128\/CMR.11.3.497","article-title":"Epidemiology of group B streptococcal disease in the United States: shifting paradigms.","volume":"11","author":"Schuchat","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"302","DOI":"10.5694\/j.1326-5377.1995.tb124596.x","article-title":"Early-onset group B streptococcal infections in Aboriginal and non-Aboriginal infants.","volume":"163","year":"1995","journal-title":"Med J Aust"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1473-3099(14)70919-3","article-title":"Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: a nationwide surveillance study.","volume":"14","author":"Bekker","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"e0214295","DOI":"10.1371\/journal.pone.0214295","article-title":"Group B streptococcal screening, intrapartum antibiotic prophylaxis, and neonatal early-onset infection rates in an Australian local health district: 2006-2016.","volume":"14","author":"Braye","year":"2019","journal-title":"PLoS One"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2393-11-16","article-title":"Delivery of maternal health care in Indigenous primary care services: baseline data for an ongoing quality improvement initiative.","volume":"11","author":"Rumbold","year":"2011","journal-title":"BMC Pregnancy Childbirth"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(11)61651-6","article-title":"Group B streptococcal disease in infants aged younger than 3 months: systematic review and metaanalysis.","volume":"379","author":"Edmond","year":"2012","journal-title":"Lancet"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1479-828X.2007.00760.x","article-title":"Institution of universal screening for group B streptococcus (GBS) from a risk management protocol results in reduction of early-onset GBS disease in a tertiary obstetric unit.","volume":"47","author":"Angstetra","year":"2007","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/01.inf.0000128782.20060.79","article-title":"Ten-year study on the effect of intrapartum antibiotic prophylaxis on early onset group B streptococcal and Escherichia coli neonatal sepsis in Australasia.","volume":"23","author":"Daley","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"F324","DOI":"10.1136\/adc.2004.066134","article-title":"Early onset neonatal meningitis in Australia and New Zealand, 1992-2002.","volume":"90","author":"May","year":"2005","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1093\/cid\/cix656","article-title":"Infant group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses.","volume":"65","author":"Madrid","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1093\/cid\/cix664","article-title":"Estimates of the burden of group B streptococcal disease worldwide for pregnant women, stillbirths, and children.","volume":"65","author":"Seale","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/cid\/cix666","article-title":"Antibody kinetics and response to routine vaccinations in infants born to women who received an investigational trivalent group B streptococcus polysaccharide CRM197-conjugate vaccine during pregnancy.","volume":"65","author":"Madhi","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R24-20250614","first-page":"83","article-title":"Group B streptococcal (GBS) disease in UK and Irish infants younger than 90 days, 2014-2015: results from prospective surveillance.","volume":"19","author":"O\u2019Sullivan","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s10096-012-1559-0","article-title":"Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project.","volume":"31","author":"Rodriguez-Granger","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/jpc.12830","article-title":"Group B streptococcal disease and genotypes in Australian infants.","volume":"51","author":"Ko","year":"2015","journal-title":"J Paediatr Child Health"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1093\/cid\/cix655","article-title":"Risk of early-onset neonatal group B streptococcal disease with maternal colonization worldwide: systematic review and meta-analyses.","volume":"65","author":"Russell","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tim.2012.12.001","article-title":"Development of intestinal microbiota in infants and its impact on health.","volume":"21","author":"Matamoros","year":"2013","journal-title":"Trends Microbiol"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1440-1754.2002.00782.x","article-title":"Is being Aboriginal or Torres Strait Islander a risk factor for poor neonatal outcome in a tertiary referral unit in north Queensland?","volume":"38","author":"Panaretto","year":"2002","journal-title":"J Paediatr Child Health"},{"key":"R31-20250614","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1046\/j.1440-1754.2002.00783.x","article-title":"Early-onset neonatal group B streptococcal infections in New Zealand 1998-1999.","volume":"38","author":"Grimwood","year":"2002","journal-title":"J Paediatr Child Health"},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ajog.2007.11.030","article-title":"Group B streptococcus and pregnancy: a review.","volume":"198","author":"Larsen","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R34-20250614","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1258\/0969141053908366","article-title":"The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Society.","volume":"12","author":"Law","year":"2005","journal-title":"J Med Screen"},{"key":"R35-20250614","doi-asserted-by":"crossref","first-page":"D58","DOI":"10.1016\/j.vaccine.2013.02.039","article-title":"GBS public awareness, advocacy, and prevention--what\u2019s working, what\u2019s not and why we need a maternal GBS vaccine.","volume":"31","author":"Burns","year":"2013","journal-title":"Vaccine"},{"key":"R36-20250614","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jama.1974.03240080040025","article-title":"Group B streptococcal infections in infants. The importance of the various serotypes.","volume":"230","author":"Baker","year":"1974","journal-title":"JAMA"},{"key":"R37-20250614","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1128\/CMR.18.1.102-127.2005","article-title":"Surface proteins of streptococcus agalactiae and related proteins in other bacterial pathogens.","volume":"18","author":"Lindahl","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"R38-20250614","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrmicro1552","article-title":"Group B streptococcus: global incidence and vaccine development.","volume":"4","author":"Johri","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"R39-20250614","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1016\/j.vaccine.2018.09.058","article-title":"Cost-effectiveness analysis of maternal immunisation against group B streptococcus (GBS) disease: a modelling study.","volume":"36","author":"Giorgakoudi","year":"2018","journal-title":"Vaccine"},{"key":"R40-20250614","doi-asserted-by":"crossref","first-page":"D20","DOI":"10.1016\/j.vaccine.2012.11.056","article-title":"Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine.","volume":"31","author":"Schrag","year":"2013","journal-title":"Vaccine"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003881","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:08:54Z","timestamp":1749946134000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003881","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,16]]}}}